Finance

Lists
016580:KRX
Whanin Pharm Co Ltd
10 300,00 KRW
-0,87%
(-90,00) 1D
19 ოქტ, 11:11:23 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 016580...
Open
10 340 KRW
High
10 350 KRW
Low
10 280 KRW
Mkt. cap
191,58 მლრ.
Avg. vol.
28,08 ათ.
Volume
2,53 ათ.
Dividend
2,91%
Quarterly dividend
75 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
9,01
52-wk high
12 140 KRW
52-wk low
9 160 KRW
EPS
1 143 KRW
Shares outstanding
18,60 მლნ.
No. of employees
631
Open
10 340 KRW
High
10 350 KRW
Low
10 280 KRW
Mkt. cap
191,58 მლრ.
Avg. vol.
28,08 ათ.
Volume
2,53 ათ.
Dividend
2,91%
Quarterly dividend
75 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
9,01
52-wk high
12 140 KRW
52-wk low
9 160 KRW
EPS
1 143 KRW
Shares outstanding
18,60 მლნ.
No. of employees
631
News stories
From web sources and news partners
The Fintech Times
The Fintech Times
·
30 წუთის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
About Whanin Pharm Co Ltd
CEOWon Beom Lee
Employees631
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
65,74 მლრდ.
65,14 მლრდ.
71,18 მლრდ.
71,42 მლრდ.
Cost of goods sold
44,31 მლრდ.
41,64 მლრდ.
44,93 მლრდ.
43,64 მლრდ.
Cost of revenue
44,31 მლრდ.
41,64 მლრდ.
44,93 მლრდ.
43,64 მლრდ.
Research and development expenses
498,72 მლნ.
251,09 მლნ.
173,17 მლნ.
158,55 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,48 მლრდ.
20,86 მლრდ.
15,87 მლრდ.
18,59 მლრდ.
Operating expense
17,87 მლრდ.
22,02 მლრდ.
16,87 მლრდ.
19,88 მლრდ.
Total operating expenses
62,18 მლრდ.
63,66 მლრდ.
61,79 მლრდ.
63,52 მლრდ.
Operating income
3,56 მლრდ.
1,48 მლრდ.
9,38 მლრდ.
7,89 მლრდ.
Other non operating income
98,76 მლნ.
70,26 მლნ.
-441,28 მლნ.
20,12 მლნ.
EBT including unusual items
4,06 მლრდ.
1,73 მლრდ.
9,98 მლრდ.
9,78 მლრდ.
EBT excluding unusual items
4,06 მლრდ.
2,01 მლრდ.
9,97 მლრდ.
9,78 მლრდ.
Income tax expense
785,02 მლნ.
-281,62 მლნ.
2,52 მლრდ.
2,08 მლრდ.
Effective tax rate
19,33%
-16,28%
25,20%
21,31%
Other operating expenses
249,44 მლნ.
322,59 მლნ.
224,25 მლნ.
582,58 მლნ.
Net income
3,28 მლრდ.
2,01 მლრდ.
7,47 მლრდ.
7,70 მლრდ.
Net profit margin
4,98%
3,09%
10,49%
10,78%
Earnings per share
-
-
-
-
Interest and investment income
501,75 მლნ.
456,44 მლნ.
1,38 მლრდ.
523,44 მლნ.
Interest expense
-7,37 მლნ.
-8,35 მლნ.
-9,05 მლნ.
-9,78 მლნ.
Net interest expenses
494,37 მლნ.
448,10 მლნ.
1,37 მლრდ.
513,67 მლნ.
Depreciation and amortization charges
228,49 მლნ.
219,37 მლნ.
218,97 მლნ.
228,93 მლნ.
EBITDA
6,03 მლრდ.
3,93 მლრდ.
11,84 მლრდ.
10,35 მლრდ.
Gain or loss from assets sale
-498,00 ათ.
282,08 მლნ.
-14,20 მლნ.
1,00 ათ.
AI content may include mistakes. Learn more
Google აპები